Upcoming events
32nd Protein Structure Determination in Industry meeting
In person
Starting from Sunday, November 10th, the ZoBio team will participate in the 32nd Protein Structure Determination in Industry meeting, which will be held at the Novotel Paris Centre Tour Eiffel in Paris, France. This year’s meeting is organized jointly by SERVIER and Synchrotron SOLEIL, with support from Hg3 Conferences.
The scientific talks will focus on the following major themes:
- Synergy of structural and computational approaches
- Structural biology across modalities
- Beyond purified protein
- Integration of data across techniques
Our scientist, Inês Justo, will present a poster titled Tailor-made Structural Biology at ZoBio, highlighting various studies we have conducted across our Structural Biology platforms.
Past events
15th Swiss Course on Medicinal Chemistry in Leysin
In person
As in previous years, ZoBio was proud to be a sponsor of the 15th Swiss Course on Medicinal Chemistry in Leysin!
This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies and technologies that support hit generation, lead finding, and lead optimization campaigns.
The course content is tailored for young scientists working in medicinal chemistry, as well as those from related disciplines such as biochemistry, pharmacy, pharmacology, or biophysics, from both the pharmaceutical and biotech industries.
ZoBio was excited to contribute to this special event. On Thursday, October 17th, our scientist Stephan Theisgen presented a talk on the application of NMR in modern drug discovery. Additionally, Marta Carneiro (Head of Structural Biology) and Johan Veerman (Head of Chemistry) shared their expertise on the use of biophysics in various aspects of drug discovery with the next generation of drug hunters.
BioJapan 2024
In person
For the first time, ZoBio was excited to participate in BioJapan 2024, an event held in conjunction with Regenerative Medicine Japan and healthTECH Japan. As Asia’s largest partnering event, it offers a comprehensive platform through its three main programs: exhibition, seminars, and partnering.
Jan Schultz attended One-on-One meetings to share insights about our services and recent developments at ZoBio and ODS with other participants.
Discovery on Target
In person
Our team was excited to participate in Discovery on Target, the industry’s premier event focused on novel drug targets and cutting-edge technologies for drug discovery professionals. The conference always showcase the latest advancements in both current and emerging “hot” targets, as well as innovative target validation strategies for developing novel therapeutic agents, from biologics to small molecules.
Masa Kobayashi, Head of Assay Development and Screening, presented the poster titled Site Selective Screening: Using Biophysics to Define a Mode of Action.